Abbott India Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

Lodha Developers Ltd, Poly Medicure Ltd, Allied Blenders & Distillers Ltd, Delhivery Ltd are among the other stocks to see a surge in volumes on BSE today, 06 January 2026.

Abbott India Ltd notched up volume of 7249 shares by 10:45 IST on BSE, a 15.24 fold spurt over two-week average daily volume of 476 shares. The stock gained 0.79% to Rs.28,400.00. Volumes stood at 145 shares in the last session.

Lodha Developers Ltd recorded volume of 4.4 lakh shares by 10:45 IST on BSE, a 11.05 times surge over two-week average daily volume of 39790 shares. The stock slipped 1.20% to Rs.1,106.90. Volumes stood at 1.31 lakh shares in the last session.

Poly Medicure Ltd registered volume of 43001 shares by 10:45 IST on BSE, a 5.93 fold spurt over two-week average daily volume of 7250 shares. The stock gained 5.41% to Rs.1,816.80. Volumes stood at 7959 shares in the last session.

Allied Blenders & Distillers Ltd saw volume of 90157 shares by 10:45 IST on BSE, a 3.73 fold spurt over two-week average daily volume of 24161 shares. The stock slipped 3.16% to Rs.556.00. Volumes stood at 31059 shares in the last session.

Delhivery Ltd clocked volume of 1.7 lakh shares by 10:45 IST on BSE, a 2.99 times surge over two-week average daily volume of 56985 shares. The stock gained 0.15% to Rs.412.95. Volumes stood at 38922 shares in the last session.

Powered by Capital Market - Live News

His tenure will be for a period of five years, effective from 14 June 2025, to 13 June 2030.

The appointment is expected to provide continued strategic leadership and drive growth initiatives for the company in the coming years.

Abbott India is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.

Abbott India?s standalone net profit climbed 15.79% to Rs 415.27 crore on 7.62% increase in revenue from operations to Rs 1,757.15 crore in Q2 FY26 over Q2 FY25.

Shares of Abbott India shed 0.63% to currently trade at Rs 29,536.05 on the BSE.

Powered by Capital Market - Live News

Abbott India has received approval from the Central Government under Section 196 of the Companies Act, 2013 for the appointment of Kartik Rajendran (DIN: 09527717) as the Managing Director of the Company, for a period of 5 (five) years, with effect from 14 June 2025 to 13 June 2030.

Powered by Capital Market - Live News

Net profit of Abbott India rose 15.80% to Rs 415.27 crore in the quarter ended September 2025 as against Rs 358.61 crore during the previous quarter ended September 2024. Sales rose 7.62% to Rs 1757.15 crore in the quarter ended September 2025 as against Rs 1632.67 crore during the previous quarter ended September 2024.

Powered by Capital Market - Live News